New Research Validates How Virtual Reality is Changing Training for the Current and Future Healthcare Workforce to Create Person-Centered Alzheimer’s Care
October 25, 2019 07:08 ET
|
Embodied Labs
Los Angeles, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Recent research from Rush University shows how new technology is changing the way the healthcare and aging care workforce are being trained by using...
SV Health Investors announces the appointment of Christian Jung, PhD as Partner in the Dementia Discovery Fund
September 09, 2019 02:00 ET
|
Dementia Discovery Fund
SV Health Investors announces the appointment of Christian Jung, PhD as Partner in the Dementia Discovery Fund Former Principal at Wellington Partners Life Sciences appointed to drive Fund’s...
The Yogen Früz Brain Project encourages Canadians to get a ”head start” on brain health
July 03, 2019 07:58 ET
|
The Brain Project - Baycrest Foundation
TORONTO, July 03, 2019 (GLOBE NEWSWIRE) -- The Yogen Früz Brain Project returns for a fourth year with a vigorous campaign to raise brain health awareness and advance groundbreaking research on...
SV Health Investors announces the appointment of Jonathan Behr, PhD as Partner in the Dementia Discovery Fund
July 02, 2019 02:00 ET
|
Dementia Discovery Fund
SV Health Investors announces the appointment of Jonathan Behr, PhD as Partner in the Dementia Discovery Fund Former founding managing director of JDRF T1D Fund joins DDF leadership team ...
National Dementia Strategy a First for Canada
June 17, 2019 13:37 ET
|
CARP
TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- CARP applauds the government’s release of Canada's first national dementia strategy, and additional funding for Phase II of the Canadian Consortium of...
GPS SmartSoles Expand Distribution Throughout Scandinavian Countries and Featured at Dementia Days Conference in Copenhagen
June 11, 2019 08:27 ET
|
GTX Corp
LOS ANGELES CALIFORNIA, June 11, 2019 (GLOBE NEWSWIRE) -- GTX Corp (OTCQB: GTXO) (“the Company”), a pioneer in the field of wearable GPS, people and asset tracking Location-Based Services (LBS) and...
Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
April 18, 2019 08:00 ET
|
Resverlogix Corp
CALGARY, Alberta, April 18, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces that BETonMACE, the Company’s event-based, phase 3 registration...
TimeSlips Storytelling Program Launches a Creative Care Revolution for People Living With Dementia
April 16, 2019 11:00 ET
|
TimeSlips
MILWAUKEE, Wis., April 16, 2019 (GLOBE NEWSWIRE) -- As our bodies and minds change with age, and frailty and memory loss threaten to separate us, the TimeSlips creative storytelling program offers...
Neuroleptics Market To Reach USD 15.41 Billion By 2026 | Reports And Data
April 15, 2019 12:39 ET
|
Reports And Data
Increase in health awareness is expected to be a prime factor driving the market growth; the rising incidences of mental disorders are also expected to grow the market demand in the future. Market...
Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases
April 01, 2019 11:00 ET
|
Resverlogix Corp
CALGARY, Alberta, April 01, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces that Dr. Jeffrey Cummings, Founding Director of the Cleveland Clinic...